rs193922525
| Cystic Fibrosis related |
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (A;G) | 3 | cystic fibrosis carrier |
| (G;G) | 0 | common in clinvar |
| Make rs193922525(A;A) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 117664770 |
| Gene | CFTR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs193922525 |
| dbSNP (classic) | rs193922525 |
| ClinGen | rs193922525 |
| ebi | rs193922525 |
| HLI | rs193922525 |
| Exac | rs193922525 |
| Gnomad | rs193922525 |
| Varsome | rs193922525 |
| LitVar | rs193922525 |
| Map | rs193922525 |
| PheGenI | rs193922525 |
| Biobank | rs193922525 |
| 1000 genomes | rs193922525 |
| hgdp | rs193922525 |
| ensembl | rs193922525 |
| geneview | rs193922525 |
| scholar | rs193922525 |
| rs193922525 | |
| pharmgkb | rs193922525 |
| gwascentral | rs193922525 |
| openSNP | rs193922525 |
| 23andMe | rs193922525 |
| SNPshot | rs193922525 |
| SNPdbe | rs193922525 |
| MSV3d | rs193922525 |
| GWAS Ctlg | rs193922525 |
| Max Magnitude | 3 |
Cystic fibrosis; c.4046G>A, p.Gly1349Asp
named i5012121 by 23andMe
| ClinVar | |
|---|---|
| Risk | rs193922525(A;A) |
| Alt | rs193922525(A;A) |
| Reference | Rs193922525(G;G) |
| Significance | Drug-response |
| Disease | Cystic fibrosis ivacaftor response - Efficacy |
| Variation | info |
| Gene | CFTR |
| CLNDBN | Cystic fibrosis ivacaftor response - Efficacy |
| Reversed | 0 |
| HGVS | NC_000007.13:g.117304824G>A |
| CLNSRC | PharmGKB Clinical Annotation UniProtKB (protein) |
| CLNACC | RCV000029536.3, RCV000211255.1, |
[PMID 995076] [The Wolff-Parkinson-White syndrome. Report of 3 cases and clinical considerations].
[PMID 9272157] Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens.
[PMID 11242048
] Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.
[PMID 12124743] Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
[PMID 17578899] Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
[PMID 19114635
] Mutations at the signature sequence of CFTR create a Cd(2+)-gated chloride channel.
